Overview

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Status:
Recruiting
Trial end date:
2023-01-30
Target enrollment:
0
Participant gender:
All
Summary
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Monastir
Treatments:
Magnesium Sulfate
Criteria
Inclusion Criteria:

- informed consent

- age >18 years

- Acute non-traumatic acute headaches

- patients treated in ED

- Magnesium sulfate and aspirin administered intravenously (IV)

Exclusion Criteria:

- Current regular use of analgesics, anticonvulsants or antidepressants

- Renal disorder with a low glomerular filtration rate (<60 ml/min)

- Neuromuscular disorder

- Pregnant woman

- Contrindication

- Allergy to NSAID

- Traumatic Headache

- Chronic headache ( headache occurring at least 15 days per month for at least 3
months)

- Hemodynamic instability